260 Madison: how much of the future NOI is already embedded in fair value and in the Series B collateral story

The main article framed the core AmTrust issue as a balance sheet that has already expanded ahead of the income stream. This continuation isolates 260 Madison because the gap is especially clean there: the asset entered the balance sheet and the Series B collateral package almost immediately, but barely entered 2025 FFO.

At first glance, the read looks calm enough. The company bought the property in December 2025, the purchase price excluding transaction costs was $211 million, and year-end fair value stood at $211.322 million, almost the same number, even after a $0.901 million write-down. There is no aggressive day-one mark-up here.

But that is only half the story. Sitting on the same year-end value is annualized adjusted NOI of only $9.669 million, average occupancy of 69.4%, a weighted-average lease term of 4.2 years, and average rent of $55 per square foot. At the same time, the company explicitly says that within five years, after capital investment and leasing more than 90% of the building, the property could reach about $20 million of NOI and average rents of $70 to $85 per square foot. So the real question is not whether there is upside. It is how much of that upside is already doing work today, both in the value and in the bond-collateral story.

Year-End Fair Value Already Carries More Than December NOI

The easy reading says the valuation is still conservative because it barely moved above cost. That is true, but incomplete. To understand what is already embedded, you have to look at the yield implied by the year-end value against the income the asset is actually generating now.

On 2025 numbers, 260 Madison's annualized adjusted NOI stands at $9.669 million. Against a fair value of $211.322 million, that is a 4.58% yield, exactly as the company presents it. That is not the yield profile of a stabilized office asset. It is the yield profile of a property still in transition.

The gap becomes sharper once management's target is placed next to it. If the asset really reaches about $20 million of NOI on the same end-2025 value base, that implies a yield of roughly 9.5%. This is not a marginal improvement. It is close to a doubling of NOI on the same value anchor.

That is the core point. End-2025 fair value has not yet booked a large capital gain on the property, but it is already built on an assumption that this is not really a 4.58%-yield asset over time. To get from the current run-rate to what the business plan implies, the company still has to deliver a new double-height lobby, upgraded building systems and roof, improved facades and retail areas, a new amenities floor, higher occupancy, and higher rents.

So there is no aggressive day-one mark-up here, but there is underwriting that is materially more ambitious than December NOI. Anyone looking only at the fact that fair value is close to cost will miss that the value already leans on a repositioning story, not on current cash flow.

Series B Looks Roomier Because Of Structure, Not Because The Asset Is Already Running Hard

The same distinction matters even more on Series B. The company issued NIS 650 million, about $203.8 million at the reporting-date exchange rate, with a 5.63% annual coupon and a single principal payment on May 31, 2030. Against that, the security package is broad: a first-ranking mortgage on the asset, assignment of all rights and proceeds of the property entity, a promissory note, a first-ranking pledge over the equity of the holding company above the property entity, and a pledge over the company's rights in the trust account.

On the surface, the covenant looks comfortable. The company reports a loan-to-collateral ratio of 62%, against an 80% breach threshold and a 75% step-up threshold for coupon adjustment. That is a very wide margin on day one.

But here too the definition matters. The ratio is calculated as the loan net of the money deposited in the trust account relative to the collateral. In other words, this is not a plain reading of the full Series B principal against the property value. If you translate the reported 62% ratio into the end-2025 fair value, you get net debt of about $131 million. Against Series B principal of roughly $203.8 million, that is a gap of about $72.7 million.

That number does not mean the entire difference is free excess cash. It does mean something else that is more important: the day-one protection in Series B relies materially on trust-account cash and collateral structure, not only on the NOI the property already knows how to generate.

That is also why it is important not to confuse a good security package with a fully proven asset. On the 2025 annualized adjusted basis, 260 Madison generates $9.669 million of NOI. The annual coupon on Series B, based on the dollar-equivalent principal at the reporting date, is about $11.5 million. So even after annualizing, current NOI is still below the gross coupon burden of the series, before CAPEX, before any other cost layer, and obviously before principal due in 2030.

That leads to the right reading. Series B looks safer today because it sits on a mortgage, assigned cash flows, a trust account, and pledged equity, not because the asset is already producing the kind of income that behaves like seasoned collateral. That is not a flaw in the structure. It is simply a distinction that matters.

There is also a small but useful clue that the package was still being completed close to the reporting date. The company says not all SNDA agreements at the pledged property had yet been signed, while the DACA had already been executed and a $1.5 million deposit had been released to the company. That does not undermine the collateral package. It does remind the reader that, at end-2025, the Series B story is still partly a set-up story, not yet a long-seasoned asset finance story.

What Has To Happen For The Story To Move From Underwriting To Execution

For both the fair value case and the Series B story to rely less on structure and more on operating proof, the company still has to close several clear gaps. The first is occupancy. At 69.4%, the building is still too far from stabilization, especially when the stated target is more than 90%.

The second is pricing. Average rent across the property is $55 per square foot, and average office rent in 2025 was $58.2 per square foot. The company is not aiming for a cosmetic change. It is aiming for a move toward $70 to $85 per square foot. That is a meaningful re-rating in rent, and it will not happen without supportive leasing conditions, physical upgrades, and a broker team that can bring in the right tenants.

The third is time. The signed-revenue schedule shows $22.447 million in 2026, $19.752 million in 2027, $20.016 million in 2028, $17.790 million in 2029, and $43.805 million from 2030 onward. That matters because it means the asset already has a contractual base. But it is still a signed-revenue layer, not proof that the asset is already generating NOI anywhere close to $20 million.

So the answer to the question in the title is two-layered. In fair value, the company has not yet booked a large future gain, because the value still sits very close to cost. But that same value already sits on a model that does not stop at current NOI. It requires a broad leasing and repositioning move. In the Series B collateral story, even more of the future is already doing work today, because the 62% ratio relies on a trust-account deduction and on a wide collateral package, not on the property already running at the income level of seasoned collateral.

That is the point the reader should not miss. 260 Madison has not yet proven the NOI on which the full story rests, but it is already supporting part of AmTrust's financing narrative. As long as leasing and CAPEX keep moving, that can look like disciplined underwriting. If the pace slows, the first crack will not appear in the indenture itself. It will appear in the gap between the comfort of fair value and collateral on paper and the cash the asset actually knows how to produce.